Showing results (581-590 of 692) with videos related to
Sort By:
Pageof 70
Oncogene|April 3, 2020
Integrative analysis of genomic amplification-dependent expression and loss-of-function screen identifies ASAP1 as a driver gene in triple-negative breast cancer progressionJichao He, Ronan P McLaughlin, Lambert van der Beek, et al.Proteomics|January 26, 2022
Novel histone modifications in microglia derived from a mouse model of chronic painPing Zhang, Jennifer Guergues, Amy R Alleyne, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1993
Hodgkin's disease: study of treatment intensities and incidences of second malignanciesM A Rodriguez, L M Fuller, S O Zimmerman, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 17, 2022
Systematic Review of In Vitro Antimicrobial Susceptibility Testing for Bacillus anthracis, 1947-2019Tucker Maxson, Thiphasone Kongphet-Tran, Thitipong Mongkolrattanothai, et al.Journal of the American Chemical Society|November 22, 2012
Azurin as a protein scaffold for a low-coordinate nonheme iron site with a small-molecule binding pocketMatthew P McLaughlin, Marius Retegan, Eckhard Bill, et al.Plos One|December 30, 2017
Phylogenetic inference of Coxiella burnetii by 16S rRNA gene sequencingHeather P McLaughlin, Blake Cherney, Janetta R Hakovirta, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 30, 2000
Rituximab anti-CD20 monoclonal antibody therapy in non-Hodgkin's lymphoma: safety and efficacy of re-treatmentT A Davis, A J Grillo-López, C A White, et al.The Journal of Pharmacology and Experimental Therapeutics|August 9, 2011
Pharmacological characterization of 2-methyl-N-((2'-(pyrrolidin-1-ylsulfonyl)biphenyl-4-yl)methyl)propan-1-amine (PF-04455242), a high-affinity antagonist selective for κ-opioid receptorsS Grimwood, Y Lu, A W Schmidt, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1991
Discordant bone marrow involvement in diffuse large-cell lymphoma: a distinct clinical-pathologic entity associated with a continuous risk of relapseL E Robertson, J R Redman, J J Butler, et al.BMJ (Clinical Research Ed.)|October 19, 2005
Legislation for smoke-free workplaces and health of bar workers in Ireland: before and after studyShane Allwright, Gillian Paul, Birgit Greiner, et al.Pageof 70